ICML in Lugano… among the things that instantly tell you where you are …

📢 NEJM just published a breakthrough discovery that unveiled a rare #geneticdefect linking #bloodformation and #immunesystem. The study was led by scientists at St. Anna Children's Cancer Research Institute CCRI, CeMM, and MedUni Wien >>>🔗 shorturl.at/rCMTU

Präzisionsmedizin in der Onkologie und Hämatologie, status quo und neue Richtungen. Ich freue mich sehr auf die Diskussion heute beim Ö1 Radiodoktor: oe1.orf.at/programm/20230…

Verena Labi ⁦labi lab innsbruck⁩ in the town. Great talk and inspiring discussion with Olaf Merkel, Richard Moriggl ⁦Richard Moriggl⁩ , Heidi Neubauer ⁦Heidi Neubauer⁩ , and Lukas Kenner ⁦lukaskenner.bsky.social🇪🇺🇺🇦⁩

“This is a revolution. Patients are demanding this approach.” Researchers are blasting patients’ cancer cells with dozens of drugs in the hope of finding the right treatment go.nature.com/42BKLSR

Our work has been highlighted by nature, along with Anthony Letai MD PhD Philipp Staber Soragni:Lab and many others. Special recognition to Albert Manzano for his excellent work. The future of precision medicine is functional! The Society for Functional Precision Medicine nature.com/articles/d4158…

New nature article on #precisionmedicine in #Vienna! An ongoing study led by Philipp Staber from #MedUniVienna tests drugs on the patient's own #cancer cells, cultured outside the body. Read more! ⬇ go.nature.com/3UGIbci

The current imprecision for cancer therapy needs marked improvement, and hopefully functional drug tests can fulfill this unmet need nature.com/articles/d4158… by Elie Dolgin feature nature

What is functional precision medicine? Check out this fascinating feature article in @nature, which also highlights findings from the FIMM cancer precision medicine team: nature.com/articles/d4158…

“This is a revolution. Patients are demanding this approach.” Researchers are blasting patients’ cancer cells with dozens of drugs in the hope of finding the right treatment go.nature.com/3UJN1FA

nature Almost every groundbreaking drug has been discovered by chance. If scientists manage to create a process where chance can be built in, it's fantastic!

nature Too bad that no journal was interested, starting from Nature. It is good, though, to get some recognition

Today we're reading about a fascinating study conducted by Philipp Staber (MedUni Wien), in which he and his team used patient-derived #Cancer #Organoids to test treatment efficacy 🧫 Learn more in this great nature article by Elie Dolgin ⤵️ buff.ly/4bELDKm

🏆We are immensely proud to announce the HemaSphere Top-Cited Article Award 2024, which goes to Peter Valent et al for the study "Updated Diagnostic Criteria and Classification of Mast Cell Disorders: A Consensus Proposal" (bit.ly/3KH3PXK). Congratulations🎉! The award

Very exciting that we can give the first HemaSphere Journal (IF = 14.6) award at #EHA2024 ! Congratulations to Peter Valent and colleagues! And more awards follow…

A great EHA annual meeting in Madrid coming to an end. Let’s get ready for an exciting EHA-SfPM Precision Medicine Meeting in Copenhagen Sept. 25-27. Abstract deadline is already June 24. Early registration deadline June 23. I hope to meet you there. ehaweb.org/meetings/preci…

Want to learn more about #functional precision medicine and meet world-leading experts? Join us in Copenhagen 25-27 Sept. 2024 for the EHA-SfPM Precision Medicine Meeting European Hematology Association The Society for Functional Precision Medicine . Abstract submission is still open. ehaweb.org/meetings/preci…

Anthony Letai MD PhD delivering opening remarks on #fpm field at joint EHA-The Society for Functional Precision Medicine conference in Copenhagen today

#EHA_SfPM2024 Philipp Staber discussing EXALT 1&2 trials in the Precision Medicine Trials session European Hematology Association The Society for Functional Precision Medicine